Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mookerjee

Showing results (421-430 of 461) with videos related to

Pageof 47
Sort By:
The Lancet. Oncology|April 1, 2019
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trialDirk Schadendorf, Axel Hauschild, Mario Santinami, et al.
Journal of Hepatology|May 5, 2015
Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical studyKarla C L Lee, Luisa A Baker, Giacomo Stanzani, et al.
Scientific Reports|May 6, 2016
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis BHai Li, Liu-Ying Chen, Nan-Nan Zhang, et al.
The Lancet. Oncology|June 9, 2017
Dabrafenib plus trametinib in patients with BRAF<sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialMichael A Davies, Philippe Saiag, Caroline Robert, et al.
Bone Marrow Transplantation|March 16, 2002
Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapyA P Rapoport, B Meisenberg, C Sarkodee-Adoo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2019
A Multispecies Cluster of GES-5 Carbapenemase-Producing Enterobacterales Linked by a Geographically Disseminated PlasmidMatthew J Ellington, Frances Davies, Elita Jauneikaite, et al.
Journal of Hepatology|February 18, 2014
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013Rajiv Jalan, Javier Fernandez, Reiner Wiest, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failureAnnarein J C Kerbert, Saurabh Gupta, Eman Alabsawy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung CancerDavid R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
Gut|December 24, 2018
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacityHannelie Korf, Johannie du Plessis, Jos van Pelt, et al.
Pageof 47

Showing results (421-430 of 461) with videos related to

Sort By:
Pageof 47
The Lancet. Oncology|April 1, 2019
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trialDirk Schadendorf, Axel Hauschild, Mario Santinami, et al.
Journal of Hepatology|May 5, 2015
Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical studyKarla C L Lee, Luisa A Baker, Giacomo Stanzani, et al.
Scientific Reports|May 6, 2016
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis BHai Li, Liu-Ying Chen, Nan-Nan Zhang, et al.
The Lancet. Oncology|June 9, 2017
Dabrafenib plus trametinib in patients with BRAF<sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialMichael A Davies, Philippe Saiag, Caroline Robert, et al.
Bone Marrow Transplantation|March 16, 2002
Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapyA P Rapoport, B Meisenberg, C Sarkodee-Adoo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2019
A Multispecies Cluster of GES-5 Carbapenemase-Producing Enterobacterales Linked by a Geographically Disseminated PlasmidMatthew J Ellington, Frances Davies, Elita Jauneikaite, et al.
Journal of Hepatology|February 18, 2014
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013Rajiv Jalan, Javier Fernandez, Reiner Wiest, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failureAnnarein J C Kerbert, Saurabh Gupta, Eman Alabsawy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung CancerDavid R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
Gut|December 24, 2018
Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacityHannelie Korf, Johannie du Plessis, Jos van Pelt, et al.
Pageof 47